Logo image of ACLS

AXCELIS TECHNOLOGIES INC (ACLS) Stock Fundamental Analysis

NASDAQ:ACLS - Nasdaq - US0545402085 - Common Stock - Currency: USD

63.11  -1.38 (-2.14%)

After market: 62 -1.11 (-1.76%)

Fundamental Rating

6

Overall ACLS gets a fundamental rating of 6 out of 10. We evaluated ACLS against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ACLS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ACLS had positive earnings in the past year.
In the past year ACLS had a positive cash flow from operations.
ACLS had positive earnings in each of the past 5 years.
Each year in the past 5 years ACLS had a positive operating cash flow.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

ACLS has a better Return On Assets (14.90%) than 86.11% of its industry peers.
ACLS's Return On Equity of 19.85% is amongst the best of the industry. ACLS outperforms 86.11% of its industry peers.
ACLS has a better Return On Invested Capital (16.22%) than 89.81% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACLS is significantly above the industry average of 11.67%.
The last Return On Invested Capital (16.22%) for ACLS is well below the 3 year average (21.34%), which needs to be investigated, but indicates that ACLS had better years and this may not be a problem.
Industry RankSector Rank
ROA 14.9%
ROE 19.85%
ROIC 16.22%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACLS has a better Profit Margin (19.75%) than 79.63% of its industry peers.
In the last couple of years the Profit Margin of ACLS has grown nicely.
ACLS's Operating Margin of 20.71% is fine compared to the rest of the industry. ACLS outperforms 79.63% of its industry peers.
In the last couple of years the Operating Margin of ACLS has grown nicely.
ACLS's Gross Margin of 44.67% is in line compared to the rest of the industry. ACLS outperforms 47.22% of its industry peers.
ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.71%
PM (TTM) 19.75%
GM 44.67%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ACLS is creating some value.
The number of shares outstanding for ACLS has been reduced compared to 1 year ago.
ACLS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ACLS has been reduced compared to a year ago.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ACLS has an Altman-Z score of 6.30. This indicates that ACLS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ACLS (6.30) is better than 64.81% of its industry peers.
The Debt to FCF ratio of ACLS is 0.34, which is an excellent value as it means it would take ACLS, only 0.34 years of fcf income to pay off all of its debts.
ACLS's Debt to FCF ratio of 0.34 is amongst the best of the industry. ACLS outperforms 82.41% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that ACLS is not too dependend on debt financing.
ACLS's Debt to Equity ratio of 0.04 is in line compared to the rest of the industry. ACLS outperforms 56.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.34
Altman-Z 6.3
ROIC/WACC1.37
WACC11.88%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

ACLS has a Current Ratio of 5.41. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.41, ACLS belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
A Quick Ratio of 4.05 indicates that ACLS has no problem at all paying its short term obligations.
The Quick ratio of ACLS (4.05) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 5.41
Quick Ratio 4.05
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for ACLS have decreased strongly by -17.23% in the last year.
Measured over the past years, ACLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 64.54% on average per year.
Looking at the last year, ACLS shows a decrease in Revenue. The Revenue has decreased by -9.97% in the last year.
Measured over the past years, ACLS shows a very strong growth in Revenue. The Revenue has been growing by 24.30% on average per year.
EPS 1Y (TTM)-17.23%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-28.37%
Revenue 1Y (TTM)-9.97%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-18.65%

3.2 Future

The Earnings Per Share is expected to decrease by -21.06% on average over the next years. This is quite bad
The Revenue is expected to decrease by -6.85% on average over the next years.
EPS Next Y-61.46%
EPS Next 2Y-21.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-22.5%
Revenue Next 2Y-6.85%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.26, the valuation of ACLS can be described as very reasonable.
ACLS's Price/Earnings ratio is rather cheap when compared to the industry. ACLS is cheaper than 97.22% of the companies in the same industry.
ACLS is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 26.62, the valuation of ACLS can be described as expensive.
Based on the Price/Forward Earnings ratio, ACLS is valued a bit cheaper than the industry average as 67.59% of the companies are valued more expensively.
ACLS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.26
Fwd PE 26.62
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

93.52% of the companies in the same industry are more expensive than ACLS, based on the Enterprise Value to EBITDA ratio.
ACLS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ACLS is cheaper than 94.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.88
EV/EBITDA 4.91
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The excellent profitability rating of ACLS may justify a higher PE ratio.
ACLS's earnings are expected to decrease with -21.06% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y-21.06%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (2/21/2025, 8:00:00 PM)

After market: 62 -1.11 (-1.76%)

63.11

-1.38 (-2.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10 2025-02-10/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners98.34%
Inst Owner Change2.58%
Ins Owners0.56%
Ins Owner Change0.44%
Market Cap2.04B
Analysts77.14
Price Target94.36 (49.52%)
Short Float %14.66%
Short Ratio7.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.49%
Min EPS beat(2)2.16%
Max EPS beat(2)20.83%
EPS beat(4)4
Avg EPS beat(4)14.53%
Min EPS beat(4)2.16%
Max EPS beat(4)23.88%
EPS beat(8)8
Avg EPS beat(8)13.92%
EPS beat(12)12
Avg EPS beat(12)16.41%
EPS beat(16)16
Avg EPS beat(16)18.88%
Revenue beat(2)1
Avg Revenue beat(2)-0.18%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)1.02%
Revenue beat(4)3
Avg Revenue beat(4)0.53%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)2.02%
Revenue beat(8)7
Avg Revenue beat(8)1.84%
Revenue beat(12)11
Avg Revenue beat(12)2.09%
Revenue beat(16)15
Avg Revenue beat(16)2.58%
PT rev (1m)-5.08%
PT rev (3m)-24.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.17%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE 10.26
Fwd PE 26.62
P/S 2.01
P/FCF 15.88
P/OCF 14.51
P/B 2.02
P/tB 2.02
EV/EBITDA 4.91
EPS(TTM)6.15
EY9.74%
EPS(NY)2.37
Fwd EY3.76%
FCF(TTM)3.97
FCFY6.3%
OCF(TTM)4.35
OCFY6.89%
SpS31.44
BVpS31.29
TBVpS31.29
PEG (NY)N/A
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 14.9%
ROE 19.85%
ROCE 18.47%
ROIC 16.22%
ROICexc 32.49%
ROICexgc 32.49%
OM 20.71%
PM (TTM) 19.75%
GM 44.67%
FCFM 12.64%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ROICexc(3y)45.35%
ROICexc(5y)37.49%
ROICexgc(3y)45.35%
ROICexgc(5y)37.49%
ROCE(3y)24.29%
ROCE(5y)20.95%
ROICexcg growth 3Y-3.61%
ROICexcg growth 5Y39%
ROICexc growth 3Y-3.61%
ROICexc growth 5Y39%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.34
Debt/EBITDA 0.19
Cap/Depr 77.05%
Cap/Sales 1.2%
Interest Coverage 250
Cash Conversion 62.14%
Profit Quality 64%
Current Ratio 5.41
Quick Ratio 4.05
Altman-Z 6.3
F-Score6
WACC11.88%
ROIC/WACC1.37
Cap/Depr(3y)109.12%
Cap/Depr(5y)96.53%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.41%
Profit Quality(3y)77.07%
Profit Quality(5y)99.84%
High Growth Momentum
Growth
EPS 1Y (TTM)-17.23%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-28.37%
EPS Next Y-61.46%
EPS Next 2Y-21.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.97%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-18.65%
Revenue Next Year-22.5%
Revenue Next 2Y-6.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.71%
EBIT growth 3Y18.31%
EBIT growth 5Y54.17%
EBIT Next Year-17.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.56%
FCF growth 3Y-3.13%
FCF growth 5YN/A
OCF growth 1Y-10.23%
OCF growth 3Y-2.13%
OCF growth 5YN/A